Search research articles
Contact Us
Filters
Showing results (151-160 of 224) with videos related to
Page
of 23
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
June 3, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation
Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock, et al.
European Heart Journal
|
December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48
Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.
JAMA Cardiology
|
January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review
Paul L Hess, Jeff S Healey, Christopher B Granger, et al.
Circulation
|
February 15, 2021
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Thomas A Zelniker, Maddalena Ardissino, Felicita Andreotti, et al.
Lancet (London, England)
|
March 15, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial
Jessica L Mega, Joseph R Walker, Christian T Ruff, et al.
Stroke
|
July 9, 2016
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
Natalia S Rost, Robert P Giugliano, Christian T Ruff, et al.
Journal of the American College of Cardiology
|
July 13, 2019
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease
Arman Qamar, Elliott M Antman, Christian T Ruff, et al.
Journal of the American Heart Association
|
August 27, 2024
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF
Linda S Johnson, Alexander P Benz, Ashkan Shoamanesh, et al.
Circulation
|
January 30, 2026
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin
Samer Al Said, Eugene Braunwald, Michael G Palazzolo, et al.
Journal of the American College of Cardiology
|
July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trial
Willibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 224) with videos related to
Sort By:
Page
of 23
Circulation. Cardiovascular Quality and Outcomes
|
June 3, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation
Brian A Bergmark, Jeong-Gun Park, Rose A Hamershock, et al.
European Heart Journal
|
December 5, 2013
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48
Deepak K Gupta, Amil M Shah, Robert P Giugliano, et al.
JAMA Cardiology
|
January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review
Paul L Hess, Jeff S Healey, Christopher B Granger, et al.
Circulation
|
February 15, 2021
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Thomas A Zelniker, Maddalena Ardissino, Felicita Andreotti, et al.
Lancet (London, England)
|
March 15, 2015
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial
Jessica L Mega, Joseph R Walker, Christian T Ruff, et al.
Stroke
|
July 9, 2016
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
Natalia S Rost, Robert P Giugliano, Christian T Ruff, et al.
Journal of the American College of Cardiology
|
July 13, 2019
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease
Arman Qamar, Elliott M Antman, Christian T Ruff, et al.
Journal of the American Heart Association
|
August 27, 2024
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF
Linda S Johnson, Alexander P Benz, Ashkan Shoamanesh, et al.
Circulation
|
January 30, 2026
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin
Samer Al Said, Eugene Braunwald, Michael G Palazzolo, et al.
Journal of the American College of Cardiology
|
July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trial
Willibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
Page
of 23